Soluble CD163 is thought to be involved in the resolution of inflammation by mechanisms that are not yet fully understood, but include inhibition of T cell activation [16], [18], and is increased in autoimmune disorders [32], [35], [36], hematological malignancies [37], malaria [38], and bacterial, but not viral meningitis [8]. The gene discussed is CD163; the disease is autoimmune disease.